| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 07/26/2000 | EP1022271A1 Cationic monobenzenic dyes, their use for the oxydative dyeing of keratinic fibres ,dye compositions and dyeing processes |
| 07/26/2000 | EP1022268A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/26/2000 | EP1022016A2 Use of cationic phenylazobenzene compounds for dyeing keratin fibres, compositions and dyeing process |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021188A1 Inhibitors of prenyl-protein transferase |
| 07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 07/26/2000 | CN1261363A Method of manufacturing sertindole |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1261253A Composition for controlling harmful bio-organisms and method therefor |
| 07/26/2000 | CN1054849C Process for producing quaternary glycine nitriles |
| 07/25/2000 | US6093823 By continuous racemate splitting via diastereomeric salt pairs with re-racemisation of the residual amino acid or amino acid derivative in the mother liquid with the aid of an optically active acid |
| 07/25/2000 | US6093820 Reacting an imide with a (substituted)alkoxyalkylsulfonic acid ester to form a n-alkoxyalkyl imide such as methoxymethyl ethosuximide; administering as anticonvulsant, antianxiety agent and muscle relaxant |
| 07/25/2000 | US6093816 For transfecting nucleic acids, proteins, oligonucleotides or peptides into prokaryotic or eukaryotic cells by forming a complex with polyanions; toxicity to the cells; nontoxic; drug delivery; antitumor-, carcinogenic agents; fungicides |
| 07/25/2000 | US6093748 Applying to an area of skin from which reduced hair growth is desired a dermatologically acceptable composition containing a non-steroidal suppressor of angiogenesis |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042007A1 Alfa-sulfenimino acid derivatives |
| 07/20/2000 | WO2000041997A1 Process for the preparation of optically active amino alcohols |
| 07/20/2000 | WO2000041469A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | CA2360356A1 .beta.-phenylalanine derivatives as integrin antagonists |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/19/2000 | EP1020451A1 Novel anilide compounds and drugs containing the same |
| 07/19/2000 | EP1020450A1 Method of manufacturing a 3-substituted-3-oxo-2-halopropionic acid amide compound and method of manufacturing a 3-substituted-3-oxo-2-(5,5-dimethylhydantoin-3-yl) propionic acid amide compound |
| 07/19/2000 | EP1020449A1 Imidazoline compounds |
| 07/19/2000 | EP1020441A1 N-heterocyclic methylpropylamine derivatives, process for producing the same and germicides |
| 07/19/2000 | EP1020434A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1020176A2 Use of cationic bis-nitrobenzenes for dyeing of keratinic fibers, dyeing compositions and dyeing process |
| 07/19/2000 | EP1019530A1 A method of treating cancer |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019381A1 Method of producing n,n'-diazole compounds |
| 07/19/2000 | EP1019370A1 Ace-inhibitor nitric salts |
| 07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 07/19/2000 | EP1019358A1 Novel compounds, their use and preparation |
| 07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 07/19/2000 | EP1019048A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | CN1260795A Quaternary ammonium compounds as tachykinin antagenists |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1260717A Use of 1-ar (alk)yl-imidazoline-2-one for treating anxietyand stress conditions |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CA2296066A1 Usage of cationic phenyl-azo-benzenic compounds for dyeing keratinic fibres, dyeing compositions and dyeing methods |
| 07/19/2000 | CA2296059A1 Novel cationic mono-benzenic dyes, their use for oxydation dyeing of keratinic fibres, dyeing compositions and dyeing methods |
| 07/18/2000 | US6090948 Inhibitors of farnesyl-protein transferase |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090940 Preparing potassium compounds by oxidizing allantoin; dissolving allantoin in a potassium hydroxide or potassium carbonate solution with an alkali metal halogen compound in the presence of potassium iodide |
| 07/18/2000 | US6090807 Use of heterocyclic compounds |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040545A1 Novel method for preparing chiral amino acids |
| 07/13/2000 | WO2000040210A2 Topical compositions comprising protected functional thiols |
| 07/13/2000 | WO2000006597A9 Endogenous constitutively activated g protein-coupled orphan receptors |
| 07/13/2000 | CA2358116A1 Novel method for preparing chiral amino acids_ |
| 07/12/2000 | EP1018508A1 Cationic monobenzenic nitrophenylene diamines, their use for dyeing keratinic fibres, dye compositions containing them and dye processes |
| 07/12/2000 | EP1018339A1 Therapeutic agent for intractable vasculitis |
| 07/12/2000 | EP1018333A2 Use of cationic monobenzene nitroanilines for dyeing keratin fibres , compositions and dyeing process |
| 07/12/2000 | EP1017681A1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 07/12/2000 | EP1017680A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 07/12/2000 | EP1017679A1 Process for the preparation of imidazoline derivatives |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017650A1 Asymmetric hydrogenation |
| 07/12/2000 | EP0690854B1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 07/12/2000 | EP0642502B1 Fungicidal imidazolinones |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | CN1260006A Complex formation between dsDNA and oligomer of heterocycles |
| 07/12/2000 | CN1259937A Carbonyl diimidazoles, their ester derivatives and method for their prodn. |
| 07/12/2000 | CN1259935A Substituted naphthopyrans |
| 07/12/2000 | CN1054376C Substituted 1H-imidazoles |
| 07/11/2000 | US6087510 Method of use of imidazolium cations |
| 07/11/2000 | US6087509 Derivatives of trifluorobenzonitriles |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/08/2000 | CA2294892A1 Use of monobenzene cationic nitroanilines in dyeing keratin fibres, dyeing compositions and dyeing processes |
| 07/08/2000 | CA2294879A1 Use of nitrated cationic dibenzene compounds in dyeing keratin fibres, dyeing compositions and dyeing processes |
| 07/06/2000 | WO2000039716A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
| 07/06/2000 | WO2000039164A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein |
| 07/06/2000 | WO2000039098A1 Synthesis of histamine dihydrochloride |
| 07/06/2000 | WO2000039097A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | WO2000039096A1 2-methylimidazoline compounds |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000039055A1 Rapid purification by polyaromatic quench reagents |
| 07/06/2000 | WO2000038716A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | WO2000020023A3 Null igf for the treatment of cancer |
| 07/06/2000 | DE19900094A1 Production of light protection formulation as e.g. paste, spray, solution or stick, involves precipitating organic filter from solution as finely-divided solid before combining in cosmetic base |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356838A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | CA2356547A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356243A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor proteins |
| 07/05/2000 | EP1016669A1 New derivatives of erythromycin, process for making them as well as their use as medicaments |
| 07/05/2000 | EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |